baber/WOPTO huggingface dataset:
Patent PT-2077165-E (PT)
Title: Sheet metal bending machine
Inventor: BEISSEL JOCHEM
IPC: B21D5/01
Filed: 2008-12-23
Abstract: The machine has hydraulically or pneumatically driven form temples (3) arranged at a side, which is opposite to the form temples, of a metal sheet (B), to bend the metal sheet into a contour, which is adjusted by forming tool temples (1). Actuators are designed as a servo-jack (2) and the form temples are arranged in a row within an area of end sections of the metal sheet bordering at edges of the metal sheet. A clamping device (10) is provided for the metal sheet, which is arranged parallel to a row of the tool temples that are isolated from the metal sheet edges.
Patent PT-2100219-E (PT)
Title: Bit generator
Inventor: KALUZHNY URI
IPC: G06F7/58
Filed: 2008-06-26
Abstract: A system comprising a feedback shift-register having L serially connected stages, and a non-linear feedback sub-system to receive input from stage n and 2n+1, and including a first AND gate having a first and second input operationally connected to the output of stage n and 2n+1, respectively, the sub-system having an output based on a value of an output of the first AND gate, a bit generator operative to generate bits, and an XOR gate having a first and second input, an output of the bit generator being operationally connected to the first input of the XOR gate, the output of the sub-system being operationally connected to the second input of the XOR gate, the output of the XOR gate being operationally connected to the input of the first stage of the shift-register. Related apparatus and methods are also described.
Patent PT-2250163-E (PT)
Title: Hepatitis c virus inhibitors
Inventor: RUEDIGER EDWARD H
IPC: A61K31/4164
Filed: 2008-02-12
Abstract: The present disclosure relates to (4-4' -diimidazolyl) biphenyls compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Patent PT-2050639-E (PT)
Title: Control device for a rail vehicle
Inventor: AURICH STEFAN
IPC: B60T8/32
Filed: 2006-02-28
Abstract: The device has a roll monitoring sensor detecting rotational speed of wheels, and a chassis monitoring device monitoring and/or diagnosizing critical conditions and damages to a chassis. The monitoring device has an electronic chassis monitoring control unit integrated with an electronic anti-skid control unit and/or electronic brake control unit and/or electronic roll monitoring control unit into a structural unit (38).
Patent PT-2274005-E (PT)
Title: Treatment of tumors by angiotensin converting enzyme 2 (ace2)
Inventor: JANZEK-HAWLAT EVELYNE
IPC: A61K38/48
Filed: 2009-04-07
Abstract: Use of a polypeptide with an angiotensin converting enzyme-2 (ACE2) activity for the manufacture of a medicament to treat tumor diseases, except lung cancer, is claimed. ACTIVITY : Cytostatic; Antiinflammatory; Vasotropic. MECHANISM OF ACTION : ACE inhibitor; Angiotensin II subtype 1 receptor antagonist.
Patent PT-778982-E (PT)
Inventor: DABBAJ RAD H
IPC: H04N5/74
Filed: 1995-09-01
Abstract: PCT No. PCT/GB95/02061 Sec. 371 Date May 13, 1997 Sec. 102(e) Date May 13, 1997 PCT Filed Sep. 1, 1995 PCT Pub. No. WO96/08031 PCT Pub. Date Mar. 14, 1996A light valve modulator of reflective operation which includes a multi-layer structure which is controlled electrostatically, comprises a transparent substrate supporting a first transparent deformable layer and a second insulating dielectric deformable layer, with a mirror layer sandwiched between, and a third, dielectric insulating layer on the outside of the second layer, at least one of the layers between the second layer and the substrate being electrically conductive, and the third dielectric layer being capable of receiving an electric charge pattern by means of one or more electron beams, whereby the mirror layer is locally deformed by electrostatic forces occurring between the third layer and the conductive layer. The twin deformably layers allow good sensitivity, while the outside dielectric layer which receives charge from an electron beam protects the deformable layers from electron bombardment and the cathode from outgassing. The modulator is for use in display tubes, particularly for projection TV.
Patent PT-932597-E (PT)
Inventor: LOCHE ANTONELLA
IPC: A61K31/19
Filed: 1997-08-07
Abstract: Use of amides of ~c-hydroxybutyric acid of formula R2-O-(CH2)3-CO-N(Q)-(CT1T2)n-R1 (I) in the treatment of drug addiction is new. R1 = mono- or polycyclic aromatic group containing carbocyclic and/or heterocyclic rings each having 5-7 atoms in the ring and being optionally substituted by 1-8C alkyl or 1-8C alkoxy (both optionally containing or substituted by double or triple bonds or by halo), aminic, 1-8C mono- or dialkylaminic groups or halo; R2 = H, 1-6C alkyl (optionally substituted by double or triple bonds or by aromatic groups); Q = H or 1-6C alkyl; n = 1-4; T1, T2 = H or 1-6C alkyl. Also claimed are: (i) a composition comprising (I); (ii) new compounds (I) where (a) R2 = alkyl (optionally substituted by one or more double or triple bonds or halo); or (b) R1 = an aromatic heterocycle and R2 is not an aromatic group; or (c) Q = 1-6C alkyl.
Patent PT-1056754-E (PT)
Inventor: STARRETT JOHN E JR
IPC: A61P25/06
Filed: 1999-01-26
Abstract: The present invention provides novel phosphate derivatives having the general formula wherein A, R1 and R2 are as defined herein, or a nontoxic pharmaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels.
Patent PT-1082110-E (PT)
Inventor: BUTLIN ROGER JOHN
IPC: C07D233/84
Filed: 1999-05-26
Abstract: The use of compounds of formula (I), and salts thereof; and pharmaceutically acceptable in vivo cleavable prodrugs of said compound of formula (I); and pharmaceutically acceptable salts of said compound or said prodrugs; in formula (I), Ring C is phenyl or a carbon linked heteroaryl ring substituted as defined within; R<SUP>1 </SUP>is an ortho substituent as defined within; n is 1 or 2; A-B is a linking group as defined within; R<SUP>2 </SUP>and R<SUP>3 </SUP>are as defined within; R<SUP>4 </SUP>is hydroxy, hydrogen, halo, amino or methyl; in the manufacture of a medicament for use in the elevation of PDH activity in warm-blooded animals such as humans is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described
Patent PT-1087975-E (PT)
Inventor: REICHENBACH HANS
IPC: C07D417/06
Filed: 1999-06-18
Abstract: Epothilone compounds of formulae (I)-(XIII) are new: Epothilone compounds of formulae (I)-(XIII) are new: Compounds (I)-(XI) are given the following names: epothilone A (I; R<1> = H; R<2>, R<8> = Me); epothilone A2 (I; R<2> = H; R<1>, R<8> = Me); epothilone A8 (I; R<8> = H; R<1>, R<2> = Me); epothilone A9 (I; R<1> = CH2OH; R<2>, R<8> = Me); epothilone B10 (II); epothilone G1 (III; R = H); epothilone G2 (III; R = Me); epothilone H1 (IV; R = H); epothilone H2 (IV; R = Me); epothilone C1 (V; R<1> = H; R<2>, R<3>, R<4> = Me; R = H); epothilone D1 (V; R<1> = H; R<2>, R<3>, R<4> = Me; R = Me); epothilone C2 (V; R<2> = H; R<1>, R<3>, R<4> = Me; R = H); epothilone D2 (V; R<2> = H; R<1>, R<3>, R<4> = Me; R = Me); epothilone C3 (V; R<3> = H; R<1>, R<2>, R<4> = Me; R = H); epothilone C4 (V; R<4> = H; R<1>, R<2>, R<3> = Me; R = H); epothilone C5 (VI; R = H); epothilone D5 (VI; R = Me); epothilone C6 (VII); epothilone C7 (VIII; R<7> = H; R<8> = Me); epothilone C8 (VIII; R<7>, R<8> = OH); epothilone C9 (VIII; R<7> = H; R<8> = CH2OH); trans-epothilone C1 (IX; R<1> = H; R<2> = Me); trans-epothilone C2 (IX; R<1> = Me; R<2> = H); epothilone I1 (X; R, R<3> = H; R<1>, R<2> = Me); epothilone I2 (X; R = H; R<1>, R<2>, R<3> = Me); epothilone I3 (X;R R<1>, R<2>, R<3> = Me); epothilone I4 (X; R, R<2> = H; R<1>, R<3> = Me); epothilone I5 (X; R<2> = H; R, R<1>, R<3> = Me); epothilone I6 (X; R<1> = H; R, R<2>, R<3> = Me); epothilone K (XI). In compound (XIII), R = H or Me.
Patent PT-1135145-E (PT)
Inventor: HART JOHN ERNEST
IPC: A61K35/16
Filed: 1999-12-01
Abstract: An endogenous mammalian material has been found which has the biological effect of causing a reduction in the mass of mammalian organs including the heart and prostate. The material has physico-chemical properties such that it appears as a compound of molecular weight between 10 and 20 kD when subjected to a purification process using membrane filtration followed by gel filtration. This material has therapeutic uses including the treatment of organ or tissue hypertrophy and hyperplasia.
Patent SG-9692-G (SG)
Title: Phase control method for video recorder motors
IPC: G11B15/467
Filed: 1992-02-01
Abstract: 1. A method for the phase control of a head drum motor in a video recorder during the reproduction of video signals recorded on a magnetic tape using a phase comparison between the head-switching pulses and the synchronizing pulses recorded on the magnetic tape, the desired phase position of the motor being adjustable, and with a device for measuring the instantaneous deviation from the desired phase position by counting clock pulses, which are fed to a counter, between the head-switching pulse and the synchronizing pulse, characterised in that a control signal R for the head drum motor is derived from the difference between the number of actual pulses I which have entered the counter and the number of preset desired pulses S, wherein R = (I-S), if a) (I-S) is positive and less than +N/2 or b) (I-S) is negative and greater than -N/2 R = (I-S)+N, if (I-S) is negative and less than -N/2 R = (I-S)-N, if (I-S) is positive and greater than +N/2, wherein N corresponds to the number of clock pulses for one revolution of the head drum motor.
Patent IE-790245-L (IE)
Title: Pyrrolidine derivative
IPC: A61P25/28
Filed: 1979-02-09
Abstract: 1-substituted 2-pyrrolidinones and pharmaceutical compositions containing same are described. The pharmaceutical compositions are useful in counteracting cerebral insufficiency or improving intellectual capacity.[EP0003602A1]
Patent IE-800494-L (IE)
Title: Aminoalkylfluorenes
IPC: A61K31/445
Filed: 1980-03-11
Abstract: A 9-aminoalkylfluorene of formula <CHEM> wherein: R<1> is hydroxy, cyano, CONR<6>R<7> in which R<6> and R<7> are independently hydrogen or alkyl; n is an integer from 3 to 5; R<2> and R<3> are independently hydrogen, alkyl, alkenyl or phenyl alkyl, or taken together with the adjacent nitrogen atom form a heterocyclic group optionally including one further heteroatom selected from oxygen and nitrogen, and which ring is optionally substituted by up to two alkyl groups; R<4> and R<5> are independently hydrogen, alkyl or halogen; provided that R<2> is hydrogen when R<1> is hydroxy; or a pharmaceutically-acceptable salt thereof, have been found to be very effective in the therapy of cardiac disorders, particularly cardiac arrythmias.
[EP0018076A1]
Patent FI-823736-L (FI)
Inventor: HEIKONEN MATTI
IPC: A23K3/03
Filed: 1982-11-02
Abstract: The invention relates to a composition and method for ensiling fodder and grain. The composition contains glucose oxidase in a carrier medium in an amount effective to produce gluconic acid upon addition to the material to be ensiled. A suitable amount of glucose oxidase to be added is from 10,000 to 10,000,000 IU perton of material to be ensiled.
Patent IE-45282-L (IE)
Title: Pharmaceutical tablet formulation
IPC: A61K31/35
Filed: 1977-05-20
Abstract: There is described a pharmaceutical tablet formulation comprising an anti-allergic drug having sodium cromoglycate like activity, as active ingredient, in combination with a lubricant and a diluent (and preferably also a flow aid and a binder) the low aid, binder, lubricant and diluent containing no material capable of causing an adverse reaction in an allergic patient. Unit dosage forms of 6,7,8,9-tetrahydro-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-carboxylic acid and 6,7,8,9-tetrahydro-S-hydroxy-4-oxo-10-propyl-4H-naphtho¢2,3-b!pyran-2-ccarboxylic acid are also described. The formulations and unit dosage forms are indicated for use in the treatment of allergies.
[CA1105835A]
Patent IE-36607-L (IE)
Title: 2 - amino -2', 6' - propionoxylidide
IPC: A61K31/16
Filed: 1972-07-27
Abstract: 1374367 2 - Amino - 2<SP>1</SP>,6<SP>1</SP> - propionoxylidide ASTRA PHARMACEUTICAL PRODUCTS Inc 28 July 1972 [28 July 1971] 35481/72 Heading C2C The novel title compound and acid addition salts thereof are prepared by reacting a 2-halo- 2<SP>1</SP>,6<SP>1</SP>-propionoxylidide, wherein halo is Cl, Br or I, with ammonia, and, if desired, converting the resulting base into acid addition salts. Pharmaceutical compositions, suitable for oral or parenteral administration, contain the above novel compound or therapeutically acceptable acid addition salts thereof together with pharmaceutically acceptable carriers. The compound possesses antiarrhythmic properties.
[GB1374367A]
Patent IE-39552-L (IE)
Title: Modifying keratinous material
IPC: D06M15/53
Filed: 1974-06-20
Abstract: 1449748 Textile treating compositions IWS NOMINEE CO Ltd and CIBA-GEIGY AG 13 June 1974 [21 June 1973] 26306/74 Headings C3B and C3R [Also in Divisions D1-D2] A composition useful in rendering wool non- filling comprises organic solvent solutions or aqueous emulsions which contain: (I) polythiols (M.W. 400-20,000) which contain at least 2 thiol groups per molecule obtained from (a) polyalcohols, (b) alkylene oxides and/or dicarboxylic acids and (c<SP>1</SP>) carboxylic acids containing thio groups or from (C<SP>2</SP>) epihalohydrins and alkali hydrogen sulphides, the polythiols containing ether and/or ester bonds, or from (a<SP>1</SP>) polycarboxylic acids, (b<SP>1</SP>) alkylene oxides or dihydric alcohols and (c<SP>1</SP>) carboxylic acids containing thio groups; (II) nitrogen containing condensation products of epoxides, fatty amines and dicarboxylic acids the equivalent ratios of epoxide groups to amino hydrogen to carboxylic acid groups being 1 : (0À1-1) : (1-0À55) and optionally aliphatic diols and/or etherified aminoplast precondensates and/or epihalohydrins; and (III) optionally stabilizers against the harmful action of light. Typical I are those of formula m#1, n=1 or 2, p#2, p+q=3 to 7, each alkylene chain is C 2-6 between consecutive oxygen atoms, R is an aliphatic radical containing at least C 2 , X is a C 1-18 aliphatic radical containing at least one thiol group. This and other examples are disclosed in Specification 1,278,934 or for example from glycerol, adipic acid, butane-1,4-diol and thioglycollic acid in a 1 : 4 : 4 : 3 molar ratio. II may be prepared from a diglycidyl ether of bisphenol A, a C 20-22 fatty amine, sebacic acid, neopentyl glycol and epichlorohydrin, e.g. as disclosed and claimed in Specification 1,313,072. III may be a phenol containing at least one sterically hindered hydroxyl group.
[GB1449748A]
Patent IE-41274-L (IE)
Title: Yarn twisting apparatus
IPC: D01H7/92
Filed: 1975-07-23
Abstract: 1512373 Friction false twisters R S GILCHRIST 22 July 1975 [25 July 1974] 32885/74 Heading DID A yarn twisting apparatus comprises a flexible tube 20/21 rotatably mounted within a curved rigid mounting 22 which constrains the flexible tube to a curved path. A driven spindle 13 is a push fit in the lower end of the flexible tube and the mounting 22 is secured at its lower end only. Sintered bearing bushes 30 are distributed along the mounting and a wick 28 supplies oil from a reservoir 42. The flexible tube comprises a helical spring 20 and an inner elastomeric sleeve 21. The rotation of the spring 20 in combination with cutaway portions 28 of the mounting provides a cooling air flow. The curvature of the tube may be involute. Specification 1353749 is referred to.
[GB1512373A]
Patent IE-45553-L (IE)
Title: Absorbent articles
IPC: A61L15/28
Filed: 1977-08-08
Abstract: An absorbent article of a size for placement against a wearer for capturing body fluids comprising, a backing sheet of fluid impervious material, a fluid pervious cover sheet, and an absorbent pad positioned intermediate the backing and cover sheets. The pad has a first layer having a mass of fibers substantially formed from a mechanical, thermomechanical, or semichemical fluff, and a second layer having a mass of fibers substantially formed from a thermomechanical, semichemical, or chemical fluff.
[US4047531A]
Patent IE-822221-L (IE)
Title: Semiconductor integrated circuit comprising a semiconductor¹substrate and interconnecting layers
IPC: H01L27/118
Filed: 1982-09-10
Abstract: A semiconductor integrated circuit including at least one conventional inner cell region and an outer cell region. The outer cell region comprising a plurality of outer cells. Each outer cell is comprised of circuit elements for achieving a predetermined logic function, in addition to circuit elements for achieving the conventional buffer function of an outer cell. Further, two or more adjacent outer cells are connected each other and act as an independent circuit so as to form a macro-cell.
[US4868630A]
Patent IE-822267-L (IE)
Title: Aminocyclopentane esters
IPC: C07D307/42
Filed: 1982-09-16
Abstract: Compounds are described of the formulae <CHEM>  in which  -COR<1> is a complex ester or haloester group,  W is alkylene,  X is cis or trans -CH=CH or -CH2CH2-,  n is 1 or 2, Y is a saturated heterocyclic amino group having 5 - 8 ring members, and R<2> is unsubstituted or substituted phenylalkyl, thienylalkyl, naphthylalkyl or cinnamyl,  and their salts and solvates. These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic and antiasthmatic agents.
Patent IE-832554-L (IE)
Title: Optical fiber connector.
IPC: B29C45/04
Filed: 1983-11-01
Abstract: An apparatus for forming miniaturized optical components such as fiber optics connector terminals in which a three-part mold set is employed to attain precise concentricity of mold cavity formations carried by two of the three mold parts which are movable axially relative to and positioned by the third or central one of the three parts. The two movable parts are each located by oppositely diverging frustoconical reference surfaces on the central part and include mold surface components which are axially positionable relative to the parts in which they are carried. The central part is supported by a shuttle for movement between a molding position and an ejection position, appropriate ejection pins being located in spaced relation to the molding position so as not to interfere with the molding operation. Precise concentricity and axial location of the three mold parts is effected in substantial measure by application of a mold closing force exclusively along the common axis of the three parts and under a force limited to a pre-established value.
Patent IE-852889-L (IE)
Title: cDNA CLONES CODING FOR POLYPEPTIDES EXHIBITING HUMAN¹GRANULOCYTE MACROPHAGE AND EOSINOPHIL CELLUAR GROWTH FACTOR¹ACTIVITY
IPC: A61P37/02
Filed: 1985-11-18
Abstract: Plasmid vectors that carry complementary DNA (cDNA) clones coding for polypeptides exhibiting human granulocyte/macrophage colony stimulating factor activity, including eosinophil growth factor activity. One of these polypeptides is about 144 amino acids in length, including a potential leader sequence. The cDNA is derived from messenger RNA isolated from a human cell source after activation with concanavalin A. The cDNA was cloned by incorporation into a plasmid vector, which was then transformed into E. coli. The plasmid vector also contained DNA segments from the SV40 virus, permitting expression of the cDNA after transfection into a mammalian host cell, such as monkey COS-7 cells.
Patent IE-883612-L (IE)
Title: Vectors and compounds for direct expression of activated human protein c
IPC: C12N15/62
Filed: 1988-12-02
Abstract: A method for the direct recombinant production of activated protein C is described. DNA compounds, vectors, and transformants useful in the method are also disclosed. The method involves transformation and culture of a host cell with a recombinant DNA vector that encodes a protein C molecules in which the activation peptide is replaced with a cleavage sequence for a cell associated protease.
[EP0319312A2]
Patent NO-800934-L (NO)
Inventor: FOELL AAKE LENNART
IPC: A01N59/12
Filed: 1980-03-31
Abstract: Iodophorous udder disinfecting preparation comprising a iodophor in the form of an alkylphenoxypoly(ethyleneoxy)-ethanol-idodine complex or a polyvinylpyrrolidone-iodine complex, whereby the complex is present in an amount corresponding to 0.01, preferably 0.1 to 0.4%, by weight of free iodine, and 5 to 10% by weight of urea, an organic and/or inorganic acid to pH 1 to 5, and water and/or other solvent to 100% by weight, and whereby the udder disinfecting preparation according to a preferred embodiment further contains an alkoxylated glucose derivative in an amount of up to 4% by weight. By means of the udder disinfecting preparation a good bactericidal effect is obtained with a low iodine concentration, as well as a good skin emollient effect. The invention further relates to a method of increasing milk production by treating the teats with such an udder disinfectant.
Patent NO-813789-L (NO)
Inventor: NILSON SVEN MELKER
IPC: F28D19/04
Filed: 1981-11-09
Abstract: The invention concerns a roll (12) comprising two superposed webs (6, 7) of material one (6) of which is formed with transverse ridges (10). At the ridge bases and tops are formed indentations (22). The other web (7) is provided with ribs (27) which are positioned in nesting relationship in the indentations, whereby the webs are secured to one another. The invention likewise concerns a method and a machine for manufacturing rolls of this kind.
Patent NO-823131-L (NO)
Title: Verktoey for fremstilling av naglespikre eller ekspansjonsspikre.
Inventor: BILLING LARS JOHAN TEODOR
IPC: B21G3/28
Filed: 1982-09-15
Abstract: Et verktøy for fremstilling av en såkalt naglespiker eller ekspansjonsspiker, dvs. en spiker som ved minst en ende har en i sideretning ekspanderbar del (52) og er fremstilt ved kutting og stansing av en spikertråd -med et enkelt arbeidsslag. Verktøyet omfatter en føring (14) for spikertråden (5). for fring av tråden i et plan vinkel- : rett til tråden, en kutteinnretning med kuttekanter (50) plassert i V-form, en stanseinnretning (30) anordnet i symmetriplanet (10) til den W. formede kuttekants (50) anordning på den åpne side av kantene og vendende bort fra spissen, og ettergivende anbringelseselementer (15) for tråden beregnet på å presses av spikertråden (5) under verk-tøyets arbeidsslag mot virkningen av en fjær ("20) , og å løfte spikeren fra kutteinnretningen (50) og stanseinnretningen (30) under returslaget for verk-tøyet .
Patent NO-831665-L (NO)
Inventor: ANDERSSON OSKAR ARNE
IPC: F24C15/20
Filed: 1983-05-10
Abstract: An arrangement for indication of the need to clean a filter, e.g. in a stove hood, has a time circuit actuated by a push button during at least 0,5 second, whereby a capacitor is charged. After the push button has returned to rest a discharging of the capacitor takes place during some 4-5 minutes, simultaneously an E-cell is charged by some 1 mA. When the discharging of the capacitor is finished the E-cell is connected in a circuit with an opposite current direction and an amperage, which is proportional to the current of the ventilator motor, and a signal lamp is put out. When the ventilator motor is not in duty, nothing is going on in the E-cell, as no current passes. A condition for making the cell work is that the voltage on it exceeds a step of some 1 V. This is the voltage step which can be used just for the reason that no reduction of time to the next cleaning shall take place when the motor works at minimum rpm. When finally the E-cell is discharged a signal lamp indicates <<clean the filter>>.
Patent NO-832234-L (NO)
Inventor: ATKINSON COLIN
IPC: C01B33/46
Filed: 1983-06-20
Abstract: This invention provides novel amorphous aluminosilicates having useful ion exchange properties and resistance to reaction with sodium silicate when used in detergent compositions. The invention also discloses routes to manufacture of the novel aluminosilicates.